The safe and effective use of methylphenidate ih the psychiatric treatment of an adolescent with epidermolysis bullosa

Epidermolizis Büllosa şiddetli klinik belirtilerle giden genetik kökenli bir deri hastalığı grubudur. Epidermolizis büllosa tanılı çocuk ve ergenlerin hastalık ile ilişkili belirtilerin yanı sıra psikososyal sorunlar da yaşadıkları bildirilmiştir. Epidermolizis büllosa tanılı çocuk ve ergenlerde psikiyatrik belirtilere sık olarak rastlanmasına karşın psikiyatrik tedavi seçenekleri üzerine sınırlı sayıda araştırma yapılmıştır. Bu olgu sunumunda epidermolizis büllosa tanılı bir ergende psikiyatrik tedavi ve dikkat eksikliği hiperaktivite bozukluğu tedavisinde metilfenidat'ın güvenli ve etkin kullanımı tartışılmıştır.Epidermolysis Bullosa is a group of inherited dermatological disorder with severe clinical symptoms. Children and adolescents with epidermolysis bullosa have been reported to experience psychosocial problems in addition to the symptoms associated with epidermolysis bullosa. Although children and adolescents with epidermolysis bullosa commonly have psychiatric symptoms, limited research has been conducted on the psychiatric treatment options. In this case report, psychiatric treatment and the safe and effective use of methylphenidate in the treatment of attention deficit hyperactivity disorder in an adolescent with epidermolysis bullosa will be discussed

Multicenter study evaluating the impact of COVID-19 outbreak on dermatology outpatients in Turkey

COVID-19 pandemic has a significant impact on public health, whether directly or indirectly. The first case was seen in Turkey on March 11, and the World Health Organization (WHO) declared a pandemic on March 12, 2020. The study aimed to document the effect of pandemic on dermatology outpatient clinics in Turkey. Fifteen tertiary hospitals from 13 provinces were included in the study, which was conducted between January 12 and May 12, 2020. The International Codes of Diseases (ICD-10) categories and patients' characteristics were evaluated before and after the pandemic. A total of 164 878 patients, 133 131 before and 31 747 after the pandemic, were evaluated. The daily hospital applications were found reduced by 77%. The three of the most frequent diagnoses; dermatitis, acne, and psoriasis remained unchanged after the pandemic. While the frequency of herpes zoster, scabies, urticaria, pityriasis rosea and sexually transmitted diseases increased significantly; allergic and irritant contact dermatitis decreased after the pandemic. The applications regarding cutaneous neoplasms were considerably reduced during the pandemic, and this effect was more pronounced in cities with higher COVID incidence. The pandemic caused a noteworthy reduction in the number of patients accessing dermatological care. The pandemic caused significant changes in the frequency of a wide range of dermatological diseases. The application of cutaneous neoplasms is considerably reduced after the pandemic, and this effect was more pronounced in cities where pandemics are frequent. Therefore, the pandemic has resulted on numerous impacts on many critical issues in dermatology and dermatological care